GlassScriptPhysician profile
Minty Nguyen
NPI 1851537823
$2,692.80
in general payments reported to CMS, 2019-2025
19 companies · $972 in 2025
The $972 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $110 · 2021: $50.94 · 2022: $282 · 2023: $173 · 2024: $653 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,541 · Entertainment: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,540.87 |
| Entertainment | $256.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $522.46 | 2022-2025 | Precision7, Eysuvis, Precision 1 |
| Optos, INC. | $500.41 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Visioneering Technologies, INC. | $366.38 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $333.04 | 2022-2025 | Infuse, Xiidra, Miebo |
| Maculogix, INC. | $127.16 | 2019 | |
| Kala Pharmaceuticals, INC. | $125.55 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $119.18 | 2024-2025 | Xdemvy |
| Coopervision INC. | $106.81 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens |
| Harrow Eye, LLC | $97.73 | 2024 | Vevye |
| Novartis Pharmaceuticals Corporation | $70.73 | 2019-2023 | |
| Biotissue Holdings INC. | $61.89 | 2023-2025 | |
| Genzyme Corporation | $50.00 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $46.12 | 2025 | |
| Abbvie INC. | $44.68 | 2022-2024 | |
| Lombart Brothers, INC. | $40.00 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $27.52 | 2022-2025 | Tyrvaya |
| Topcon Healthcare, INC. | $23.00 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.27 | 2019 | |
| Shire North American Group INC | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minty Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.